x
Visit our new Mobile Website next time you access NetDania with your mobile device

RELMADA THERAPEUTICS INC. - COMMON STOCK

3.53
10-19:59:52 GMT
-0.27
-7.11%
ISIN:N/A

Figures - RELMADA THERAPEUTICS INC. - COMMON STOCK

Open
3.80
Close
3.80
Year Change
-14.73
Year % Change
-14.73%
52 Week High
7.22
52 Week Low
2.36
Volume
79440
Inc. Vol
2706

News - RELMADA THERAPEUTICS INC. - COMMON STOCK

12-21:09 GMT
Deadly Floods Kill Hundreds Across The Globe: Here’s Where The Devastation Is Happening (Photos)
Source: Forbes World, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-21:04 GMT
Sunday Conversation: Jane Goodall on Her Mission In 2024, Giving Hope
Source: Forbes World, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-20:51 GMT
CPI, Retail Earnings and Other Can't Miss Items this Week
Source: NASDAQ Stocks, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-20:47 GMT
2 Stocks That Could Create Lasting Generational Wealth
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-20:47 GMT
12-20:40 GMT
Despite Lower Out-Of-Pocket Costs, Insulin Affordability Is Still A Critical Issue
Source: Forbes World, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-20:34 GMT
The State Pre-School Gap Continues To Grow
Source: Forbes World, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-20:31 GMT
‘Beyond’ $20 Trillion By 2030—Jack Dorsey’s Plan To Turbocharge The Bitcoin Price
Source: Forbes World, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-20:30 GMT
Interview Question: "How Do You Define Success?"
Source: Forbes World, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:29 GMT
3 Natural Gas Stocks to Invest in Rising AI Data Center Demand
Source: NASDAQ Stocks, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for VRT
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
3 Top AI Stocks Ready for a Bull Run
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for MRVL
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for NEE
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for LRCX
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for CSCO
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for ABBV
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for AMGN
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for KO
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for ANET
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for ACN - Warren Buffett
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for TMO
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for INTU
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for MS
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
Guru Fundamental Report for RTX - Martin Zweig
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:25 GMT
12-19:14 GMT
VAT In The Digital Age: Impact Of Revised Proposals On EU Businesses
Source: Forbes World, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-19:03 GMT
The Stock Market Is Going To Crash, Or Is This Time Different?
Source: NASDAQ Stocks, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-18:58 GMT
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
12-18:58 GMT
3 High-Yield Stocks on Track to Grow Their Payouts
Source: NASDAQ US Markets, Symbol: RELMADA THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
39481.34
52.85
0.13%
5219.14
0.93
0.02%
18151.89
22.26
0.12%
61082.00
153
0.25%
18801.96
52.99
0.28%
38219.67
-229.83
-0.60%
3154.55
0.23
0.01%
8426.31
-0.38
0.00%
18950.88
281.24
1.51%
7745.54
3.81
0.05%
22055.20
97.7
0.44%
2359.62
13.16
0.56%
82.68
-1.475
-1.75%
1.07692
0.00032
0.03%
155.665
-0.025
-0.02%
1.25157
-0.0004
-0.03%
0.66006
0.00025
0.04%
1.36670
0.00016
0.01%
167.66800
0.01
0.01%
0.85994
0.00078
0.09%
194.84900
-0.037
-0.02%
0.90554
-0.00027
-0.03%
0.97543
-0.00016
-0.02%
0.60154
-0.0003
-0.05%
105.31400
0.113
0.11%
Top Gainers
Name
Last
+/-
%
0.02
0.01
129.35%
2.58
1.38
115.00%
8.88
4.41
98.66%
0.01
0.00
63.89%
0.09
0.03
52.08%
0.02
0.01
50.00%
0.03
0.01
47.18%
17.44
5.25
43.07%
5.29
1.48
38.84%
0.11
0.03
36.25%
Top Losers
Name
Last
+/-
%
3.31
-11.36
-77.44%
0.01
-0.01
-51.20%
0.20
-0.15
-42.86%
2.36
-1.48
-38.54%
0.04
-0.03
-37.20%
0.04
-0.02
-36.24%
0.25
-0.14
-35.09%
0.58
-0.27
-32.04%
0.25
-0.11
-30.56%
0.00
0.00
-29.79%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy